SEC Form 4 · accession 0001062993-15-003743
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher U Missling
Officer — President, CEO, CFO, Treasurer · Director
Period of report
Jul 6, 2015
Accepted (ET)
Jul 7, 2015 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jul 6, 2015 | P | 1,000 | $0.4695 | A | 4,010,000 | D | |
| Common stockF2 | Jul 7, 2015 | P | 1,000 | $0.5099 | A | 4,011,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchases reported in this Form 4 were effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 3, 2015.
- F2Includes 4,000,000 shares of restricted common stock, 3,000,000 shares of which have vested pursuant to the achievement of certain objectives.